DRUG · Unmapped registry intervention
Sublingual film containing dexmedetomidine (BXCL501)
Find medicine records ·
Find other trials using this name
Clinical trial
Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia
NCT04268303
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Unmapped registry intervention
Placebo Film
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedDexmedetomidine in the Treatment of Agitation Associated With Schizophrenia
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Agitationunresolved
Schizophreniaverified · MONDO: schizophrenia
Schizo Affective Disorderunresolved
Schizophreniform Disordersunresolved
Interventions
Sponsors & collaborators
BioXcel Therapeutics Inclead sponsor
Cognitive Research Corporationcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04268303 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.